Viewing Study NCT00079950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:18 PM
Ignite Modification Date: 2026-02-03 @ 12:01 AM
Study NCT ID: NCT00079950
Status: SUSPENDED
Last Update Posted: 2012-09-06
First Post: 2004-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Sponsor: Enzon Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma, Soft Tissue View
Keywords:

Keywords

Keyword Brief Keyword Text View
None soft View
None sarcoma View
None metastatic View